Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
London Medical Laboratory
Life Sciences
Testing the market…clinically speaking
By
Dr Martin Hall
04 Oct 2021
The Monthly: October 2021
01 Oct 2021
Cizzle Biotechnology
Life Sciences
Keeping on-track
By
Dr Martin Hall
30 Sep 2021
Filta Group
Consumer
Strong recovery continues
By
Jason Streets
24 Sep 2021
Fidelity European Trust Plc
Financials
FEV: follow the money
By
Mark Thomas
21 Sep 2021
City of London Investment Group
Financials
Results full of cash
By
Dr Brian Moretta
20 Sep 2021
Cizzle Biotechnology
Life Sciences
Strategic collaboration with SGSC
By
Dr Martin Hall
20 Sep 2021
Fidelity China Special Situations Plc
Financials
China growth story + market-beating style
By
Mark Thomas
20 Sep 2021
Diurnal Group Plc
Life Sciences
All set for three pivotal trials
By
Dr Martin Hall
16 Sep 2021
ICG Enterprise Trust
Investment Companies
ICGT in personal pensions: do as the professionals do
By
Mark Thomas
14 Sep 2021
Oakley Capital Investments
Investment Companies
1H’21: 35% EBITDA growth drives 26% NAV return
By
Mark Thomas
13 Sep 2021
Prev
1
...
28
29
30
31
32
...
84
Next
